Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Ovarian Neoplasms 17Uterine Cervical Neoplasms 9Endometrial Neoplasms 7Carcinoma, Non-Small-Cell Lung 7Lung Neoplasms 6Fallopian Tube Neoplasms 4Carcinoma, Ovarian Epithelial 4Uterine Neoplasms 3Pancreatic Neoplasms 3Prostatic Neoplasms 2Neoplasms 2Neoplasm Metastasis 2Genital Neoplasms, Female 2Esophageal Neoplasms 2Colorectal Neoplasms 2Uterine Cervical Dysplasia 1Urogenital Neoplasms 1Urinary Bladder Neoplasms 1Trophoblastic Neoplasms 1Triple Negative Breast Neoplasms 1Thymus Neoplasms 1Thymoma 1Stomach Neoplasms 1Small Cell Lung Carcinoma 1Salivary Gland Neoplasms 1Recurrence 1Rectal Neoplasms 1Peritoneal Neoplasms 1Neuroendocrine Tumors 1Neoplasms by Site 1

Interventions

Colposcopy 18Imiquimod 14Conization 12Papillomavirus Vaccines 9Vaccines 7Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 7Cryotherapy 7Biopsy 6Acetic Acid 6human papillomavirus vaccine, L1 type 16, 18 5Vaginal Smears 5Papanicolaou Test 5Human Papillomavirus DNA Tests 5Blood Specimen Collection 5Watchful Waiting 4GX-188 vaccine 4Surveys and Questionnaires 3Cisplatin 3VGX-3100 2Transurethral Resection of Prostate 2Topotecan 2Spectrometry, Fluorescence 2Restraint, Physical 2Proflavine 2Polymerase Chain Reaction 2Paclitaxel 2Mass Screening 2Indomethacin 2Immunohistochemistry 2Human Papillomavirus Recombinant Vaccine nonavalent 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Uterine Cervical Dysplasia × Pemetrexed × Gynecologic × Clear all
NCT00190983 2009-11-20

A Trial for Patients With Advanced/Recurrent Cervical Cancer

Eli Lilly and Company

Phase 2 Completed
29 enrolled 14 charts
Gynecologic

Uterine Cervical Dysplasia, Genital Neoplasms, Female, Uterine Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡